Cutaneous T-cell lymphoma

Bexarotene for CTCL | Therapeutic Cheat Sheet
Bexarotene for CTCL
by Adrianna Gonzalez Lopez, MD on
Cutaneous T cell lymphoma (CTCL) is the most common primary cutaneous lymphoma, and in some patients, it could be persistent for decades. Therapy for CTCL depends on disease stage and response to prior treatments. In this month’s installment of Therapeutic Cheat Sheets, we will discuss use of bexarotene for the treatment of CTCL. BEXAROTENE THERAPEUTIC CHEAT SHEET Compiled by: Adrianna Gonzale …
Patient Buzz: Misdiagnosed Skin Conditions
Differential diagnosis
by Allison Sit on
Women’s Health recently wrote an article about four skin conditions that are commonly misdiagnosed. Why do primary care providers sometimes misdiagnose common skin conditions? What conditions are challenging for dermatologists to diagnose? What steps can a dermatologist take to make a differential diagnosis? For expert advice, I contacted Steve Daveluy, MD, FAAD, associate professor and pr …
Widespread Skin Necrosis Secondary to Gemcitabine Therapy
Skin Necrosis
INTRODUCTION Cutaneous side effects are relatively common in chemotherapy but vary in frequency and severity depending on the medication, dose, duration, pharmacokinetics, and pharmacodynamics. Gemcitabine, a pyrimidine nucleoside analogue, is a common oncologic agent used in the treatment of a variety of malignancies such as cancers of the head and neck, lung cancer, breast cancer, pancreatic …
Cutaneous T-Cell Lymphoma CTCL – Part 1
Cutaneous T-cell lymphoma
by Misty Eleryan, MD, MS on
My Obsession with Cutaneous T-Cell Lymphoma (CTCL) – A Sneak Peek In preparation for an exciting new Resident-led session at the upcoming ODAC conference, titled “My Obsession with CTCL”, I wanted to give you an overview of this broad category of diseases. I just remember my first Dermatology Grand Rounds presentation as a new resident was covering the topic of sarcoidosis. In this discussi …